Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Century Therapeutics, Inc. IPSC
$3.34
-$0.03 (-1.04%)
На 18:04, 12 мая 2023
+536.23%
Потенциал через год
Ранг: 3
Ключевые показатели
-
Marketcap
196446392.00000000
-
week52high
14.00
-
week52low
2.81
-
Revenue
5199000
-
P/E TTM
-1
-
Beta
0.00000000
-
EPS
-2.26000000
-
Last Dividend
0.00000000
-
Next Earnings Date
15 мая 2023 г. в 04:00
Описание компании
Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 for relapsed, refractory B-cell lymphoma. It is also developing CNTY-103, a CAR-iNK candidate targeting CD133 + EGFR for recurrent glioblastoma; CNTY-102, a CAR-iT targeting CD19 + CD79b for relapsed, refractory B-cell lymphoma and other B-cell malignancies; CNTY-104, a CAR-iT or CAR-iNK multi-specific candidate for acute myeloid leukemia; and CNTY-106, a CAR-iNK or CAR-iT multi-specific candidate for multiple myeloma. Century Therapeutics, Inc. was founded in 2018 and is headquartered in Philadelphia, Pennsylvania.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| HC Wainwright & Co. | Buy | 23 мая 2022 г. | |
| Piper Sandler | Overweight | Overweight | 17 мая 2022 г. |
| SVB Leerink | Outperform | Outperform | 29 апр 2022 г. |
| SVB Leerink | Outperform | Outperform | 19 ноя 2021 г. |
| SVB Leerink | Outperform | 13 июл 2021 г. | |
| Guggenheim | Buy | 31 окт 2022 г. | |
| HC Wainwright & Co. | Buy | Buy | 14 ноя 2022 г. |
| SVB Leerink | Outperform | Outperform | 06 янв 2023 г. |
| Piper Sandler | Overweight | Overweight | 06 янв 2023 г. |
| HC Wainwright & Co. | Buy | Buy | 06 янв 2023 г. |
| EF Hutton | Buy | Buy | 06 янв 2023 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Quimi Daphne | A | 39744 | 39744 | 01 окт 2022 г. |
| Walbert Timothy P | A | 39744 | 39744 | 01 окт 2022 г. |
| Versant Venture Capital VI, L.P. | D | 11452014 | 364800 | 09 авг 2022 г. |
| Versant Venture Capital VI, L.P. | D | 11816814 | 550000 | 09 авг 2022 г. |
| Carlo Rizzuto | A | 19872 | 19872 | 09 июн 2022 г. |
| JIMENEZ JOSEPH | A | 19872 | 19872 | 09 июн 2022 г. |
| Casdin Eli | A | 19872 | 19872 | 09 июн 2022 г. |
| Blackwell Kimberly | A | 19872 | 19872 | 09 июн 2022 г. |
| Riva Alessandro | A | 19872 | 19872 | 09 июн 2022 г. |
| BUTITTA CYNTHIA M | A | 19872 | 19872 | 09 июн 2022 г. |
Новостная лента
Century Therapeutics to Present at Upcoming Investor Conferences
GlobeNewsWire
01 февр 2023 г. в 07:00
PHILADELPHIA, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Century Therapeutics (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in immuno-oncology, today announced that members of the management team will participate in the following investor conferences in February:
How Will Early 2023 Layoffs Affect These 5 Biotech Stocks?
MarketBeat
26 янв 2023 г. в 04:03
The 2023 calendar year has already been rocky for many biotech companies. Just three weeks into the new year, layoffs are already plaguing the industry.
5 Best and Worst Performing Small-Cap Stocks in Dec 2022
24/7 Wall Street
17 янв 2023 г. в 22:59
Small-cap stocks usually suffer more than mid- and large-cap stocks when the market as a whole is struggling, and when the market is rallying, they could offer higher returns as well.
After Plunging -29.84% in 4 Weeks, Here's Why the Trend Might Reverse for Century Therapeutics, Inc. (IPSC)
Zacks Investment Research
17 янв 2023 г. в 11:18
Century Therapeutics, Inc. (IPSC) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Top 5 Health Care Stocks That May Surge - Graphite Bio (NASDAQ:GRPH), Fate Therapeutics (NASDAQ:FATE)
Benzinga
10 янв 2023 г. в 07:33
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.